echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The Lancet publishes a review article on neurofibromatosis research in China by Li Qingfeng's team from the Ninth Affiliated Hospital

    The Lancet publishes a review article on neurofibromatosis research in China by Li Qingfeng's team from the Ninth Affiliated Hospital

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Recently, LANCET NEUROLOGY (IF 59.

    Due to the low awareness of NF1 among the public, the scientific community has not paid enough attention to it.

    For a long time, NF1, as a rare intractable disease, has long been a pain for patients and a difficulty for doctors

    Professor Li Qingfeng led the NF1 team to establish the first pilot site for neurofibromatosis drug treatment in China in Boao, Hainan, where neurofibromatosis patients who meet the indications for drug treatment receive "sympathetic medication"

    In 2021, China's first expert consensus on clinical diagnosis and treatment of NF1 (2021), led by Professor Li Qingfeng from the Ninth Affiliated Hospital, with Associate Professor Wang Zhichao as the first author, and experts and scholars from multiple disciplines, will be published in the Chinese Journal of Rehabilitation and Reconstruction Surgery.

    Neurofibromatosis type 1 (NF1) is a rare autosomal dominant disorder that typically presents as multiple café-au-lait spots and neurofibromas on the skin, or plexiform neurofibromas involving the main nerves, often with There are skeletal deformities, learning disabilities, central nervous system tumors and other problems, which lead to social barriers in patients

    The Department of Rehabilitation and Rehabilitation of the Affiliated Ninth People's Hospital is one of the largest diagnosis and treatment centers for neurofibromatosis type 1 in China.

    Paper link:

    Chen Gang
    Affiliated Ninth Hospital
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.